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Abstract 1 
Allergies and their characteristic TH2-polarized inflammatory reactions affect a substantial 2 
part of the population. Since there is increasing evidence that the immune system modulates 3 
plasticity and function of the central nervous system (CNS), we investigated the effects of 4 
allergic lung inflammation on the hippocampus – a region of cellular plasticity in the adult 5 
brain. The focus of the present study was on microglia, the resident immune cells of the CNS, 6 
and on hippocampal neurogenesis, i.e. the generation of new neurons. C57BL/6 mice were 7 
sensitized with a clinically relevant allergen derived from timothy grass pollen (Phl p 5). As 8 
expected, allergic sensitization induced high serum levels of allergen-specific 9 
immunoglobulins (IgG1 and IgE) and of TH2 cytokines (IL-5 and IL-13). Surprisingly, fewer 10 
Iba1
+
 microglia were found in the granular layer and subgranular zone of the hippocampal 11 
dentate gyrus and also the number of Iba1
+
MHCII
+
 cells was lower, indicating a reduced 12 
microglial surveillance and activation in the hippocampus of allergic mice. Neurogenesis was 13 
analyzed by labeling of proliferating cells with bromodeoxyuridine (BrdU) and determining 14 
their fate 4 weeks later, and by quantitative analysis of young immature neurons, i.e. cells 15 
expressing doublecortin (DCX). The number of DCX
+
 cells was clearly increased in the 16 
allergy animals. Moreover, there were more BrdU
+
 cells present in the hippocampus of 17 
allergic mice, and these newly born cells had differentiated into neurons as indicated by a 18 
higher number of BrdU
+
NeuN
+
 cells. In summary, allergy led to a reduced microglia presence 19 
and activity and to an elevated level of neurogenesis in the hippocampus. This effect was 20 
apparently specific to the hippocampus, as we did not observe these alterations in the 21 
subventricular zone/olfactory bulb system, also a region of high cellular plasticity and adult 22 
neurogenesis.   23 
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Introduction 1 
 2 
In comparison to the broad interest focusing on the influence of TH1 inflammatory parameters 3 
on the CNS (e.g. (Cunningham et al., 2009; Henry et al., 2009; Jurgens et al., 2012; Jurgens 4 
and Johnson, 2012; Kahn et al., 2012; Kranjac et al., 2012; Valero et al., 2014), only a small 5 
number of studies deals with the effects of TH2 immunity on the brain (e.g. (Sarlus et al., 6 
2012; Sarlus et al., 2013; Tonelli et al., 2009)). This is in striking contrast to the fact that 7 
chronic TH2-polarized immune reactions, which are a main characteristic of allergies, affect a 8 
substantial and increasing part of the population world-wide (Bieber et al., 2011; Fiocchi et 9 
al., 2011; Pawankar et al., 2011). The WAO estimates that 400 million people in the world 10 
suffer from allergic rhinitis and 300 million from asthma (Brozek et al., 2010; Pawankar et al., 11 
2011). 12 
 13 
Allergies are misguided responses of the immune system in which normally non-pathogenic 14 
stimuli, such as tree and grass pollen, dust mites, or animal dander, lead to immune responses 15 
characterized by the synthesis of allergen-specific IgE antibodies, the activation of TH2 16 
immune cells and the production of the key TH2 cytokines IL-4, IL-5, and IL-13 (for a review 17 
see: (Bloemen et al., 2007; Galli et al., 2008)). At later stages of a persisting allergic immune 18 
response, also other TH subsets, e.g. TH1 and TH17, may be activated leading to an increased 19 
production of pro-inflammatory cytokines, such as IFNγ and TNFα, or the TH17 cytokine IL-20 
17 (reviewed in (Holgate and Polosa, 2008)). 21 
 22 
There is increasing evidence that allergic reactions might influence immune status and 23 
functions of the CNS. In a rodent model of allergic rhinitis, reduced social interaction and 24 
anxiety-like behavior were observed, accompanied by the induction of a TH2-biased cytokine 25 
mRNA profile (IL-4, IL-5, IL-13) in the olfactory bulb and the prefrontal cortex (Tonelli et 26 
al., 2009). In another model of airway-induced allergy, the allergic reaction was associated 27 
with increased levels of the immunoglobulins IgG and IgE in CNS tissue, and with enhanced 28 
tau phosphorylation (Sarlus et al., 2012), a risk factor for the development of Alzheimer’s 29 
disease. Chronic airway-induced allergy in mice modifies gene expression in the brain toward 30 
insulin resistance and inflammatory responses (Sarlus et al., 2013). In mice, in which a food 31 
allergy was induced shortly after weaning, reduced social behavior, increased self-grooming, 32 
reduced alternation in the T maze as well as decreased dopamine levels in the prefrontal 33 
cortex were observed (de Theije et al., 2014). Another study in juvenile mice, which were 34 
exposed to a long-term OVA-based asthma regime, showed impaired learning and memory in 35 
the Morris water maze, disturbed long-term potentiation in the hippocampal CA1 region and 36 
reduced cell proliferation in the hippocampal neurogenic niche (Guo et al., 2013). 37 
 38 
There are only few findings suggesting that allergic reactions, like allergic rhinitis and 39 
asthma, affect cognitive functions in humans. Individuals suffering from seasonal allergic 40 
rhinitis, for example, perform worse in cognitive tests (Hartgerink-Lutgens et al., 2009). 41 
Moreover, there is a positive correlation between allergic rhinitis and mood disorders, such as 42 
anxiety and depression (reviewed in (Sansone and Sansone, 2011)). Similarly, children with 43 
asthma have higher rates of depression, behavioral disorders, and learning disabilities 44 
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(Blackman and Gurka, 2007; Blackman and Conaway, 2012). There is also a correlation 1 
between allergies and epilepsy in children (Silverberg et al., 2014). While elderly asthma 2 
patients can profit from anti-asthmatic treatment, at least temporarily, with improved 3 
cognitive functions (Bozek et al., 2010), patients suffering from seasonal allergic rhinitis have 4 
a slower processing speed during attention tasks – also during symptom-free periods (Trikojat 5 
et al., 2015). 6 
 7 
While there are indications that chronic systemic inflammation might contribute to 8 
neurodegenerative diseases (reviewed in (Cunningham, 2013; Czirr and Wyss-Coray, 2012; 9 
Perry, 2010)), the data about a possible influence of allergy on neurodegeneration is still 10 
conflicting. A longitudinal study in a population-based twin sample showed a positive 11 
association between a history of atopy and dementia (Eriksson et al., 2008). However, another 12 
study reported recently that Alzheimer’s disease (AD) patients who also suffered from 13 
allergies had an improved biomarker profile, closer resembling that of healthy subjects (i.e. 14 
higher Aβ42 levels in the cerebrospinal fluid), and had a better cognitive performance, which 15 
might indicate a beneficial effect of allergy on AD (Sarlus et al., 2015). 16 
 17 
There is accumulating evidence that the immune system, e.g. via cytokines and chemokines, 18 
strongly modulates CNS functions like learning and memory, and also adult neurogenesis, the 19 
generation of new neurons in the adult CNS (reviewed in (Yirmiya and Goshen, 2011)). Thus, 20 
the aim of the present study was to investigate if an allergic reaction influences the 21 
hippocampus, specifically the dentate gyrus, which presents one of two classical neurogenic 22 
niches in the adult CNS and which is known for its central role in cognitive functions 23 
(reviewed in (Bond et al., 2015; Marin-Burgin and Schinder, 2012)). In comparison, we also 24 
analyzed the subventricular zone (SVZ), from which neuronal progenitors migrate via the 25 
rostral migratory stream to the olfactory bulb (OB) to integrate into the neuronal networks, the 26 
second classical neurogenic niche (reviewed in (Bond et al., 2015)). 27 
 28 
Based on these data, we hypothesized that a systemic allergic reaction affects neurogenesis 29 
and microglia in the hippocampus. Further, we expected that the effect of a TH2-polarized 30 
allergic response on microglial activation might differ from the well described reaction to a 31 
systemic LPS challenge.  32 
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Materials and methods 1 
 2 
Animals 3 
Female C57BL/6 mice (aged 10-12 weeks) were purchased from Charles River Germany and 4 
afterwards kept under standard animal housing conditions with free access to food and water 5 
at the animal facility at the University of Salzburg, Austria. All experimental procedures were 6 
approved by the Austrian Ministry of Science and carried out in compliance with international 7 
ethical guidelines. 8 
 9 
Allergy induction 10 
Recombinant Phl p 5.0101 (Phl p 5) was purchased from Biomay AG. The animals were 11 
divided into 2 groups: controls (n = 9) and allergy model (n = 10). The control group received 12 
all treatments using only the vehicle solution (phosphate-buffered saline, PBS). Animals of 13 
the allergy group were immunized intraperitoneally (i.p.) with 1 μg Phl p 5 adjuvanted with 14 
Al(OH)3 (Alu-Gel-S from Serva) in PBS (50% v/v, total volume: 200 μl,) at weeks 1, 2, and 15 
7. In week 11, starting 4 days before the perfusion (day 75), this group was challenged three 16 
times with a daily dose of 5 μg Phl p 5 in 40 μl PBS intranasally (i.n.) (on days 71, 74 and 17 
75). During this procedure, all mice (also the controls) were briefly anesthetized with 18 
isoflurane.  19 
 20 
Analysis of blood parameters 21 
Blood samples were taken at the end of the experiment (day 75), and incubated for 1 h at 22 
37 °C. After centrifugation (10 min), the sera were collected and stored at -80 °C until 23 
measurements. Serum levels of Phl p 5-specific IgG1 and IgG2c were determined by a 24 
luminescence-based ELISA, and biologically functional IgE was measured in vitro by a rat 25 
basophil leukemia (RBL) cell assay. Additionally, cytokines, chemokines and the growth 26 
factor VEGFα were measured with a Luminex Multiplex Assay (Milliplex MAP Mouse 27 
Cytokine/Chemokine Magnetic Bead Panel, Merck) according to the manufacturer’s 28 
instructions. 29 
 30 
Luminescence-based ELISA assay to analyze of serological IgG levels 31 
Levels of Phl p 5-specific IgG1 and IgG2c were determined using a luminescence-based 32 
ELISA assay as previously described (Weinberger et al., 2013). In short, 96-well plates for 33 
immunoassays (Greiner) were coated for 24 h at 4°C with recombinant Phl p 5 (per well 50 µl 34 
of 1 μg/ml Phl p 5 in PBS). Afterwards, plates were washed with 0.1% Tween-20 in PBS 35 
(v/v) and incubated with blocking buffer (0.1% (v/v) Tween 20 and 2% (w/v) skim milk in 36 
PBS, pH 7.5) for 1 h at RT, before washing the plates again. Then, the plates were incubated 37 
with serum diluted (1:10,000) in blocking buffer for 1 h at RT, washed again, before the horse 38 
radish peroxidase (HRP)-conjugated antibodies for the detection of IgG1 (Zymed) or IgG2c 39 
(Zymed) (diluted 1:1,000 in blocking buffer) were added to the wells for 1 h at RT. After that, 40 
the luminometric assay (BM chemiluminescence substrate, Roche) was developed by adding 41 
the substrate (luminol diluted 1:2 in H2O) to each well. After 3 min incubation, 42 
chemiluminescence (photon counts/second) was determined using an Infinite M200 Pro Plate 43 
Reader (Tecan). 44 
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 1 
Rat basophil leukemia (RBL) cell assay to measure biologically functional IgE 2 
The serum level of IgE was measured using a RBL cell assay as previously described 3 
(Weinberger et al., 2013). Briefly, RBL-2H3 cells (ATCC CRL-2256) were seeded in 96-well 4 
culture plates (Greiner) at a density of 6x10
5
 cells/ml and grown over night in 100 μl culture 5 
medium per well at standard culture conditions (37°C, 95% relative humidity, 5% CO2). The 6 
culture medium was RPMI 1640 supplemented with 10% (v/v) heat-inactivated fetal calf 7 
serum, 100 U/ml penicillin and 100 µg/ml streptomycin, 4 mM L-glutamine, 2 mM sodium 8 
pyruvate, 10 mM HEPES, and 100 µM 2-mercaptoethanol. Next day, cells were incubated for 9 
2 h with different serum dilutions (1:50, 1:100, and 1:200). Untreated wells were used to 10 
assess background and maximum release values. To remove unbound antibodies, plates were 11 
washed twice with 200 μl Tyrode’s buffer (137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl2, 12 
1.8 mM CaCl2, 0.4 mM NaH2PO4, 5.6 mM D-glucose, 12 mM NaHCO3, 10 mM HEPES, and 13 
0.1% (w/v) bovine serum albumin; pH 7.2). Then the cells were incubated for 30 min in 14 
100 µl of 0.1 µg/ml recombinant Phl p 5 diluted in Tyrode’s buffer to induce crosslinking of 15 
FcεR-bound IgE and degranulation of RBL cells. To determine maximum release, cell 16 
membranes were disrupted by adding 10 µl of a 10% (v/v) Triton X-100 solution. After that, 17 
50 μl of the cell culture supernatants were transferred into fresh 96-well plates (Greiner), 18 
where they were incubated for 1 h with 50 μl assay solution at a final concentration of 80 μM 19 
4-methylumbelliferyl N-acetyl-b-D-glucosaminide (4-MUG, Sigma) in 0.1 M citrate buffer 20 
(pH 4.5). To stop the reaction, 100 µl glycine buffer (0.2 M glycine and 0.2 M NaCl, pH 10.7) 21 
were added and fluorescence (in relative fluorescence units) was measured in a fluorescence 22 
microplate reader (Infinite M200 Pro, Tecan). Background values were subtracted from all 23 
measured values, and the results were presented as percentage of the maximum release value. 24 
 25 
Detection of proliferating cells to determine cell fate 26 
For the detection of proliferating cells, a solution of 10 mg/ml bromodeoxyuridin (BrdU) 27 
(Sigma-Aldrich) in 0.9% NaCl (w/v), in a dosage of 50 mg/kg body weight, was once injected 28 
i.p. in week 7 on day 47 (four weeks before the end of the experiment).  29 
 30 
Bronchoalveolar lavage (BAL) and tissue processing 31 
In week 11, mice were deeply anaesthetized by i.p. injection of a mixture of ketamine 32 
(273 mg/kg body weight), xylazine (71 mg/kg body weight) and acepromazine (4 mg/kg body 33 
weight) in a physiological NaCl solution. During deep anesthesia (which was carefully 34 
evaluated), tracheotomy and a BAL were performed. In short, the lungs were washed twice 35 
with 1 ml of ice cold PBS and the fluid was collected back into the syringe. This BAL fluid 36 
was stored on ice until flow cytometric analysis (FACS Canto II, BD Bioscience). 37 
 38 
After BAL, mice were transcardially perfused, first with a 0.9% NaCl (w/v) solution, and then 39 
with phosphate-buffered 4% paraformaldehyde (pH 7.4). Afterwards, brains were removed, 40 
postfixed overnight in 4% paraformaldehyde, cryoprotected in phosphate-buffered 30% 41 
sucrose (w/v), and sectioned on dry ice with a sliding microtome. The sections (thickness: 42 
40 µm) were stored at -20 °C in a cryoprotection solution (made of equal parts glycerin, 43 
0.2 M phosphate buffer, ethylene glycol and H2O). 44 
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Analysis of the BAL fluid 1 
BAL samples were centrifuged (7 min, 250 x g, 4 °C) and 450 µl of supernatants were taken 2 
and mixed with 50 µl of 10% bovine serum albumin (BSA) and 1% NaN3 in H2O and frozen 3 
at -80 °C. Cytokine levels in the BAL fluid were analyzed using a Luminex Multiplex Assay 4 
(MILLIPLEX MAP Mouse Cytokine/Chemokine Magnetic Bead Panel, Merck) according to 5 
the manufacturer’s instructions. 6 
 7 
For analysis of different immune cell populations in the BAL fluid, cell pellets were re-8 
suspended in 100 µl of the remaining supernatant and transferred into a 96-well V-bottom 9 
plate (Greiner), and then centrifuged (5 min, 250 x g, 4 °C). After that, cell pellets were re-10 
suspended in 30 µl antibody staining mix: CD45-PerCP/Cy5.5 (1:400, 30-F11, Biolegend), 11 
CD4-BV421 (1:200, GK1.5, Biolegend), CD19-PE-Cy7 (1:100, 6D5, Biolegend), Gr-1-APC 12 
(1:200, RB6-8C5, eBioscience), Siglec-F-PE (1:200, E50-2440, BD Biosciences), CD8-FITC 13 
(1:100, 53-6.7, eBioscience) and incubated for 10 min on ice. Afterwards, the cells were 14 
washed with 100 µl FACS buffer (0.5% BSA and 2 mM EDTA in PBS), and then incubated 15 
for 5 min at RT in 100 µl Red Blood Cell (RBC) lysis buffer (eBioscience) to remove residual 16 
red blood cells. After another washing step (using FACS buffer), cell pellets were re-17 
suspended in 120 µl FACS buffer and transferred into FACS tubes. Cells were analyzed on a 18 
FACS Canto II flow cytometer (BD Bioscience) and data were recorded for 30 sec at a rate of 19 
120 µl/min to calculate the absolute cell numbers per BAL. For flow cytometric analysis, at 20 
first total leukocytes were gated based on their expression of CD45. The FSC/SSC plots were 21 
used to exclude cell debris, and then in FSC-W/FSC-A plots the single cells were gated. 22 
Neutrophils were identified based on their high Gr1 expression. The other cells were gated 23 
according to their expression of CD4, CD8, and SiglecF. SiglecF
+
 is highly expressed on 24 
eosinophils and monocytes. Monocytes were then separated from eosinophils by their 25 
autofluorescence in the BV-510 channel. In general, the observed CD19 staining was weak; 26 
therefore, CD19
+
 cells were identified after exclusion of the previously gated cell types. 27 
 28 
Immunohistochemistry 29 
Immunohistological stainings were performed as previously described (Kandasamy et al., 30 
2014), using the following antibodies and dilutions. Primary antibodies: rat anti-BrdU (1:500, 31 
BU1/75, AbD Serotec), rabbit anti-CD68 (1:500, ab125212, Abcam), rabbit anti-doublecortin 32 
(1:250, 4604, Cell Signaling), guinea pig anti-GFAP (1:500, GP52, Progen), rabbit anti-Iba1 33 
(1:300, 019-19741, Wako), goat anti-Iba1 (1:250, ab107159, Abcam), anti-mouse MHCII (I-34 
A/I-E) (1:100, 14-5321-82, eBioscience), mouse anti-NeuN (1:500, A60, Merck Millipore), 35 
mouse anti-PCNA (1:500, sc-56, Santa Cruz). Secondary antibodies: donkey anti-rat Alexa 36 
488, donkey anti-goat, -mouse Alexa 568, donkey anti-rabbit, -guinea pig Alexa 647 (all 37 
1:1000, Invitrogen, Life technologies), donkey anti-rat Cy5, donkey anti-mouse biotinylated 38 
(1:1000, Jackson Immuno Research), goat anti-rabbit biotinylated, rabbit anti-rat biotinylated 39 
(all 1:500, Vector Labs). Cell nuclei were stained with 4′,6-diamidino-2-phenylindole 40 
dihydrochloride at a concentration of 0.5 μg/μl (DAPI; Sigma-Aldrich). 41 
 42 
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Image documentation and analysis were done using a Zeiss Axioplan light microscope or a 1 
confocal scanning laser microscope (Zeiss LSM 700) with LSM software (ZEN 2012) for 2 
fluorescent stainings. 3 
 4 
Quantitative analysis of immunohistological stainings 5 
Image acquisition and quantification were done blinded (i.e. without knowing group or mouse 6 
number). For quantitative analysis, a representative tenth of one brain hemisphere was 7 
analyzed by collecting every tenth section, with an interval of 400 µm between sections. This 8 
tenth of a hemisphere was used for immunohistochemistry with a chromogenic dye. The total 9 
number of stained cells within the regions of interest was counted using a Zeiss Axioplan light 10 
microscope. In the dorsal hippocampal dentate gyrus, the total numbers of PCNA
+
, BrdU
+
, 11 
Iba1
+
 and DCX
+
 cells were counted. In addition, the total number of BrdU
+
 cells in the SVZ 12 
was determined.  13 
 14 
To investigate the cell fate of BrdU
+
 cells in the dorsal dentate gyrus, a BrdU/NeuN/GFAP 15 
fluorescence staining was analyzed. For each animal, z-stacks of the dorsal dentate gyrus were 16 
made in a tenth brain hemisphere on a Zeiss LSM 700 laser scanning microscope. In these 17 
image stacks all BrdU
+
 cells were counted, and at the same time, it was also determined if 18 
these cells were co-labelled for NeuN or GFAP. Thus, the percentage of BrdU
+
NeuN
+
 or 19 
BrdU
+
GFAP
+
 cells was determined per animal. Similarly, BrdU
+
 cells in the granular cell 20 
layer of the OB were analyzed in a region of 400 µm x 400 µm x 40 µm. 21 
 22 
To analyze the activation state of Iba1
+
 cells in the dorsal dentate gyrus, the numbers of 23 
Iba1
+
MHCII
+
 and Iba1
+
CD68
+
 cells were counted in z-stacks (generated using a with Zeiss 24 
LSM 700 equipped with the Zeiss ZEN 2012 software) of 4 visual fields (400 µm x 400 µm x 25 
40 µm) per animal. For the OB, one visual field of the granular cell layer was analyzed. 26 
 27 
To estimate the analyzed volume for each region, the corresponding tissue area in the middle 28 
of the stack was measured and then multiplied by 40 μm. Then the cell densities were 29 
determined by dividing the total number of counted cells by this volume and presented as 30 
cells/mm
3
.  31 
 32 
Statistics 33 
Data are shown as means + standard deviation (S.D.). Statistical significance was determined 34 
in Prism 5 (Graphpad Software Inc) using independent samples t-tests (the corresponding p-35 
values are represented as: *p < 0.05, **p < 0.01, ***p < 0.001). To adjust for multiple 36 
comparisons between the two groups, we computed for each large family of comparisons 37 
(cytokines in serum, cytokines in BAL fluid, and cell types in BAL fluid) a Holm-Šídák 38 
correction for multiple t-tests (at a global alpha level of 0.05) and reported the multiplicity 39 
adjusted p values (in brackets) in addition to the unadjusted p values. Statistical outliers were 40 
identified using the Grubb’s test (p < 0.05) in the QuickCals GraphPad Software 41 
(http://graphpad.com/quickcalcs/grubbs1). 42 
 43 
  44 
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Results 1 
 2 
Allergic mice have a TH2-polarized immune reaction 3 
The allergen used in the present study, Phl p 5, is derived from timothy grass pollen and 4 
frequently responsible for allergy symptoms in human patients (Matthiesen and Lowenstein, 5 
1991; Sekerkova et al., 2012). After sensitization, lung inflammation was induced in C57BL/6 6 
mice via intranasal application of the allergen (Experimental set-up see Fig. 1A). To exclude 7 
that any of the observed effects were caused by experimental procedures (e.g. handling of the 8 
animals or anesthesia), the controls underwent all experimental steps at the same time as the 9 
allergy group and received the vehicle solution (PBS) during sensitization and challenge.   10 
 11 
First, the allergic status of the sensitized mice was confirmed by measuring blood and lung 12 
parameters. For this, the levels of allergen-specific immunoglobulins were determined. In 13 
mice, the TH2 cytokine IL-4 is necessary for the immunoglobulin class switch to IgG1 and 14 
IgE, whereas the TH1 cytokine IFNγ would cause a class switch to IgG2c. Thus, the 15 
immunoglobulin measurements (Fig. 1B-C) showed that mice sensitized to the allergen had a 16 
TH2-polarized immune response, since we observed high IgG1 (Fig. 1B) and IgE (Fig. 1C) 17 
levels, whereas IgG2c was not significantly elevated in comparison to controls (Fig. 1B). 18 
 19 
As expected, high serum levels of TH2 cytokines IL-5 and IL-13 were observed in the allergy 20 
model (Fig. 1D). The TH2 cytokine IL-4 was also modestly, but not significantly, elevated in 21 
the allergy model in comparison to controls. The cytokine IL-10 (Fig. 1D), which can be 22 
derived from TH2 but also from regulatory Tr1 cells, was, not significantly, increased in 23 
allergic mice. Additionally, we found a modest increase of the pro-inflammatory cytokines 24 
IFNγ, TNFα, IL-1β, IL-2 and IL-6 in the sera of allergic mice (Fig. 1E). Also, the serum 25 
levels of the TH17 cytokine IL-17A were slightly, but not significantly, elevated in the allergy 26 
model (Fig. 1E). 27 
 28 
The chemokine CCL2, which is an effective attractant for monocytes, was significantly 29 
increased in the allergy model, whereas surprisingly CCL11, a signaling molecule attracting 30 
eosinophils was significantly decreased in the serum of allergic mice (Fig. 1F). The growth 31 
factor VEGFα was also increased in the allergy model (Fig. 1G). 32 
 33 
In the lungs of the allergic mice similar changes were observed. In the BAL fluid the levels of 34 
the typical TH2 cytokines (IL-4, IL-5 and IL-13) and of IL-10 were increased (Fig. 2A). The 35 
TH1 cytokine IFNγ and the TH17 cytokine IL-17A were also slightly increased (Fig. 2B). In 36 
contrast to the serum, the chemokine CCL11 was markedly elevated in the BAL fluid, which 37 
was expected since CCL11 is important for the recruitment of eosinophils (Fig. 2C). Indeed, 38 
the number of infiltrating leukocytes and eosinophils was very high in the BAL fluid of 39 
allergic mice (Fig. 2D). Also neutrophils, T cells (CD4
+
 and CD8
+
) and CD19
+
 B cells 40 
invaded the lungs in the allergy model (Fig. 2D). Unexpectedly, we found a small, but 41 
significant, reduction in the number of monocytes in the BAL fluid of allergic mice (Fig. 2D). 42 
 43 
 44 
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Allergy modulates microglia in the hippocampal neurogenic niche 1 
The neurogenic niche of the hippocampus is located in the subgranular zone (SGZ) of the 2 
dentate gyrus. The neurons which are generated from the neural stem cells in the SGZ then 3 
integrate into the granular layer (GL) of the dentate gyrus (reviewed in (Bond et al., 2015)). 4 
Microglia, the tissue macrophages of the CNS, play an important part in regulating the 5 
neurogenic niche ((reviewed in (Kokaia et al., 2012; Sierra et al., 2014)). Since these cells are 6 
especially reactive to immune signals from the periphery (Hoogland et al., 2015), we checked 7 
whether they are influenced by allergy using the marker Iba1 which labels microglia and 8 
macrophages. Surprisingly, a significant reduction in the number of Iba1
+
 cells was observed 9 
in allergic mice in the GL and SGZ of the hippocampal dentate gyrus (control: 2456 ± 295 10 
cells per hemisphere, allergy: 1924 ± 275 cells per hemisphere; p < 0.0013) (Fig. 3A).  11 
 12 
To check if also other commonly used markers for microglial activation were altered in 13 
allergic mice, we quantified MHCII, which is important for antigen presentation, and CD68, 14 
which is associated with lysosomes. In both, controls and in the allergy group, these markers 15 
were mainly found in intracellular compartments presumably lysosomes or endosomes (Fig. 16 
4C). While significantly fewer Iba1
+
 cells also expressed MHCII in allergic mice (control: 17 
7172 ± 913 cells/mm³, allergy: 5555 ± 766 cells/mm³; p < 0.0001) (Fig. 4D), there was no 18 
change in the numbers of Iba1
+
CD68
+
 cells (control: 10103 ± 609 cells/mm³, allergy: 10300 ± 19 
1002 cells/mm³; p < 0.6345) (Fig. 4E).  20 
 21 
Allergy activates microglia in the granular cell layer of the OB 22 
The OB is the brain region into which SVZ-derived newly generated neurons integrate 23 
(reviewed in (Bond et al., 2015)). Using the same markers as in the hippocampus, we 24 
analyzed microglial activation in the OB (Fig. 4A) to find out if the changes we observed 25 
were specific for the hippocampus. 26 
 27 
In contrast to the hippocampal neurogenic niche, allergy elevated the number of Iba1
+
 28 
microglia in the granular cell layer of the OB (control: 9890 ± 546 cells/mm³, allergy: 11271 29 
± 985 cells/mm³; p < 0.0027). In parallel, also the numbers of Iba1
+
CD68
+
 cells (control: 30 
9370 ± 638 cells/mm³, allergy 10676 ± 1123 cells/mm³; p < 0.0098) and of Iba1
+
MHCII
+
 31 
cells (control: 8433 ± 919 cells/mm³, allergy: 9829 ± 915 cells/mm³; p < 0.0060) increased. 32 
This indicates that allergy leads to more activated microglia in the OB. 33 
 34 
Allergy increases the number of immature DCX
+
 neurons in the hippocampus 35 
To investigate hippocampal neurogenesis in Phl p 5-sensitized mice after re-exposure to the 36 
allergen, we first quantified total cell proliferation in the GL and SGZ of the dorsal dentate 37 
gyrus. The marker PCNA labelled cells which were proliferating shortly before the animals 38 
were sacrificed, i.e. during allergen challenge (Fig. 5A). This analysis showed that the number 39 
of PCNA
+
 proliferating cells in the dentate gyrus was not changed in the allergy model 40 
(control: 1579 ± 223 cells per hemisphere; allergy: 1606 ±179 cells per hemisphere; 41 
p < 0.7847) (Fig. 5B). 42 
 43 
Provis
i nal
12 
 
Next, we evaluated if there were changes in immature DCX-expressing neurons in the 1 
hippocampal neurogenic niche (Fig. 5C). Indeed, allergic mice had an increased number of 2 
DCX
+
 cells in the GL and SGZ of the hippocampus (control: 2659 ± 337 cells per 3 
hemisphere, allergy: 3395 ± 591 cells per hemisphere; p < 0.0064) (Fig. 5D). 4 
 5 
Taken together these results suggest that even though the proliferation rate at the end of the 6 
experiment was not changed, either more immature neurons were generated already earlier 7 
after the sensitization phase or the differentiation of DCX
+
 cells was delayed. 8 
 9 
Allergy increases production of mature neurons (BrdU
+
NeuN
+
) in the hippocampus 10 
For cell fate analysis, mice received a single injection of BrdU after the last sensitization step 11 
and 4 weeks before the end of the experiment. BrdU, a thymidine analogue, incorporates into 12 
the DNA of proliferating cells. Thus, a BrdU
+
 nucleus indicates a cell that had been dividing 13 
at the time of injection, i.e. after the sensitization was completed, and survived until the end of 14 
the experiment. A quantification of the total number of BrdU
+
 cells in the GL and SGZ of the 15 
dorsal dentate gyrus showed that the allergic mice had a significantly higher number of BrdU
+
 16 
cells than the control group (control: 206 ± 40 cells per hemisphere, allergy: 339 ± 107 cells 17 
per hemisphere; p < 0.0046) (Fig. 6A and 6B). 18 
 19 
Since the increase in BrdU
+
 cells in the hippocampal GL and SGZ of allergic mice (Fig. 2B 20 
and 2D) could not be explained by microglial cells, as since their numbers actually decreased, 21 
we further analyzed the cell fate of these BrdU
+
 cells and investigated if they became NeuN
+
 22 
mature neurons or GFAP
+
 astrocytes or radial glia (Fig. 6C). In allergic mice, the number of 23 
BrdU
+
NeuN
+
 mature neurons increased significantly (control: 1264 ± 271 cells/mm³, allergy: 24 
1766 ± 382 cells/mm³; p < 0.0065) (Fig. 6D). There was also a slight, but not significant 25 
increase in the number of BrdU
+
GFAP
+
 cells (control: 446 ± 154; 566 ± 211; p < 0.2027) 26 
(Fig. 6D). However, the percentages of BrdU
+
 cells which were either positive for NeuN or 27 
GFAP were unchanged (Fig. 6E). 28 
 29 
These results indicate that the observed increase in BrdU
+
 cells is due to an increased net 30 
production of mature NeuN
+
 neurons in the hippocampal neurogenic niche and not caused by 31 
a change in the differentiation fate of the cells. 32 
 33 
Allergy neither affects the numbers of BrdU
+
 cells in the SVZ nor the cell fate of BrdU
+
 34 
cells in the OB 35 
To assess if the pro-neurogenic effect of allergy was specific for the hippocampus, or if it was 36 
also affecting the other classical neurogenic niche, we analyzed BrdU
+
 cells in the SVZ (Fig. 37 
7A-B) and OB (Fig. 7C-D). In the SVZ, in both groups, hardly any BrdU
+
 cells were left (Fig. 38 
7A), and there was no significant difference between the groups (control: 76 ± 33 cells per 39 
hemisphere, allergy: 93 ± 37 cells per hemisphere; p < 0.3188) (Fig. 7B). Next, we did an 40 
analysis of cell fate of BrdU
+
 cells in the OB (Fig. 7C-D). There was no significant difference 41 
in the densities of BrdU
+
 cells between the groups (control: 9114±1425 cells/mm³, allergy: 42 
9396±2105 cells/mm³; p < 0.7534) and also the density of BrdU
+
NeuN
+
 (control: 8059±1149 43 
cells/mm³, allergy: 8216±1819 cells/mm³; p < 0.8363) or BrdU
+
GFAP
+
 cells (control: 44 
Provis
i nal
13 
 
889±355 cells/mm³, allergy: 990±451 cells/mm³; p < 0.6178) did not change significantly 1 
(Fig. 7D). In both cases, around 90% of these BrdU
+
 cells in the OB were also positive for 2 
NeuN (control: 88.6±2.9%, allergy: 87.5±3.6%; p < 0.4834) (Fig. 7E).  3 
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Discussion 1 
 2 
In the present study, the effects of a TH2-polarized systemic inflammation on the neurogenic 3 
niche in the hippocampus were analyzed in a model of grass pollen allergy. Surprisingly, 4 
allergy seems to have a positive impact on the production of new neurons and leads to a 5 
down-regulation of microglial activation in this region. 6 
 7 
The analysis of immunological parameters in sera and lungs confirmed that in the allergy 8 
model a TH2-polarized allergic reaction was induced. As expected, the allergy model showed 9 
the typical immunoglobulin pattern for an allergic immune response (high levels of allergen-10 
specific IgE and IgG1, low levels of IgG2c). In addition to a robust increase of TH2 cytokines 11 
in serum and BAL fluid, also a modest, but significant, induction of pro-inflammatory 12 
cytokines was observed. Moreover, CCL2 an important chemoattractant for monocytes was 13 
increased in the serum. These immune parameters are in line with what has been described for 14 
patients suffering from allergies affecting the airways (Holgate et al., 1997; Kuna et al., 15 
1996). 16 
 17 
Microglia are the tissue macrophages of the CNS and are responsible for CNS immune 18 
surveillance. They react to pathogenic events and are “activated” in a multi-step process 19 
(Kettenmann et al., 2011), which leads to an upregulation of specific proteins, e.g. MHCII for 20 
antigen-presentation or CD68 which is associated with lysosomes and endosomes (Boche et 21 
al., 2013). Microglia are also part of the hippocampal neurogenic niche, and have regulatory 22 
functions there (Gemma and Bachstetter, 2013; Sierra et al., 2014). The allergic immune 23 
response in our model affected these immune cells in the hippocampal neurogenic niche in an 24 
unexpected way: Allergy led to a “deactivation” of microglia in this region, since both, their 25 
numbers and their MHCII expression were reduced. 26 
 27 
Actually, there is one study showing that – in the absence of inflammatory stimuli – the rate 28 
of neurogenesis and microglial numbers, specifically in the dentate gyrus, are inversely 29 
correlated (Gebara et al., 2013). This fits to our results, since we observed an increase of 30 
neurogenesis accompanied by a reduction in microglial numbers (Iba1
+
 cells). The further 31 
reduction of microglia that are expressing MHCII (from 58.8 ± 5.1% in controls to 44.7 ± 32 
4.6% in allergic mice, p < 0.00001; data not shown) might suggest that the affected microglia 33 
were either less phagocytic or less inclined to present the phagocytosed antigens as MHCII is 34 
involved in this process. A reduced phagocytic activity could be explained by a lack of 35 
cellular debris due to an increased survival of newly generated immature DCX
+
 neurons, 36 
since superfluous progenitors are normally phagocytosed by microglia (Sierra et al., 2010). 37 
However, the number of microglia expressing CD68, a widely used marker for microglial 38 
activation, which is located in phagosomes and lysosomes, was unaffected, suggesting that 39 
allergy affects predominantly antigen presentation. 40 
 41 
At first glance, our findings are in contrast to numerous studies which found that microglia 42 
are activated by systemic inflammation (Hoogland et al., 2015). However, those studies 43 
exclusively used stimuli inducing TH1-polarized immune responses, i.e. LPS, bacteria, or 44 
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viruses (Hoogland et al., 2015), which could explain the different outcome. Moreover, in our 1 
allergy model, the deactivation of microglia seemed to be specific for the hippocampal 2 
dentate gyrus, since we actually observed an activation of microglia accompanied by 3 
upregulation of MHCII and CD68 in the OB (Fig. 4). The OB is not only the region into 4 
which SVZ-derived newly generated neurons are integrated, but also seems to contain an 5 
especially reactive sub-population of microglia (Lalancette-Hebert et al., 2009), which could 6 
explain why allergy has an opposite effect on microglia in this region. Alternatively, the 7 
intranasal delivery of the allergen might have a much more pronounced effect on the OB 8 
system compared to the hippocampus. For this reason, it might be interesting to investigate 9 
whether this difference between hippocampal and OB microglia is also present in allergy 10 
models affecting other parts of the organism, e.g. the skin.  11 
 12 
Why are microglia deactivated in the hippocampus of allergic mice? It is tempting to assume 13 
that this might be a regulatory mechanism protecting the hippocampus, which is central for 14 
many important processes, from the immune response in the periphery. An alternative 15 
hypothesis would be that this down-regulation is directly caused by the elevated levels of TH2 16 
cytokines in the blood. It is even more challenging to speculate about the functional 17 
consequences of this observed down-regulation of microglial activation below the normal 18 
“surveying state” in the young hippocampus. If immune surveillance in the hippocampus is 19 
down-regulated for extended periods, this may have detrimental consequences. However, with 20 
the current experimental set-up we do not know if this microglial deactivation is transient or 21 
persists for longer periods. Of course, the allergy-induced changes in hippocampal microglia 22 
were rather subtle, which could be due to the fact that the starting point for the down-23 
regulation was a young healthy condition. Therefore, it would be highly interesting to 24 
investigate what allergy does to microglia in the aged CNS, which might already be somewhat 25 
primed for a pro-inflammatory activation (Norden and Godbout, 2013).  26 
 27 
Concomitantly with microglial deactivation, hippocampal neurogenesis was increased, i.e. we 28 
observed higher numbers of DCX
+
 immature neurons and BrdU
+
NeuN
+
 mature neurons. 29 
Since BrdU was injected after the sensitization period (4 weeks before the end of the 30 
experiment) and the allergen challenge started only 4 days before the animals were sacrificed, 31 
it seems that already the sensitization has an impact on hippocampal neurogenesis. With the 32 
current experimental setup it is only possible to analyze the cumulative effect of both phases, 33 
but it would be interesting to study the effect of sensitization alone, and further time points in 34 
which also the challenge period is extended. Additionally, it would be worth investigating 35 
whether alternative sensitization and challenge routes (e.g. in a model for food allergy) have a 36 
similar impact on microglia and neurogenesis in the hippocampus. 37 
 38 
So far, we can only hypothesize that the observed increase in hippocampal neurogenesis may 39 
also have functional consequences on long-term potentiation or learning and memory. For 40 
this, further studies including electrophysiological analysis and behavioral tests are needed.  41 
 42 
We did not observe any changes in proliferation at the end of the challenge period. This is in 43 
contrast to a study which showed that in immature mice, chronic asthma leads to a reduced 44 
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proliferation in the hippocampal neurogenic niche (Guo et al., 2013). An explanation for these 1 
different results could be that the latter study particularly investigated animals of a very young 2 
and, thus, probably more vulnerable age, starting the OVA sensitization in 3-weeks-old mice 3 
and then extended the OVA challenge over a period of 9 weeks (Guo et al., 2013), whereas 4 
the present allergy model started in young adult mice (2-months-old) and the actual challenge 5 
period only lasted for 4 days. Moreover, commercially available OVA often contains 6 
substantial levels of LPS, which lead to additional and potentially confounding immune 7 
responses, whereas the Phl p 5 used in the present study was essentially LPS-free. However, 8 
similar to the study of Guo and colleagues, also in our model an increase of serum levels of 9 
VEGFα was observed. Within the neurogenic niche, VEGFα supports neurogenesis 10 
((Schanzer et al., 2004), reviewed in (Kokaia et al., 2012)), and it also has been shown that 11 
peripheral VEGF is necessary for exercise-induced neurogenesis (Fabel et al., 2003). Taken 12 
together, these results suggest that a peripheral increase of VEGF might affect neurogenesis, 13 
but this is probably context-dependent. 14 
 15 
High serum levels of CCL11 (eotaxin-1) were recently described to inhibit hippocampal 16 
neurogenesis (Villeda et al., 2011). While in the BAL fluid, as expected, elevated levels of 17 
CCL11 were only found in the allergy group, in serum both, control mice as well as allergic 18 
mice displayed high levels of CCL11. In fact, serum levels of CCL11 were even slightly 19 
decreased in allergic mice. This is in line with data showing that eotaxin is elevated in nasal 20 
secretion of allergic patients during the pollen season, whereas no difference was observed in 21 
eotaxin serum levels – neither in or out of pollen season, nor between healthy and allergic 22 
donors (Pullerits et al., 2000). 23 
 24 
Depending on the type of immune response, systemic inflammation might elicit diverse 25 
effects on the CNS. Our data suggests that a TH2-polarized allergic immune response might 26 
promote neurogenesis and down-regulate microglia in the hippocampus. However, at the 27 
moment it is not clear if this also has a beneficial effect on CNS functions and what happens 28 
if this immune response persists for a longer time. Clearly, more experiments investigating the 29 
impact of different types of systemic inflammation on the CNS are needed to further the 30 
understanding about the interplay between peripheral immune activation and CNS functions.  31 
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Figure legends 1 
 2 
Figure 1 Experimental design and serological analysis. (A) Setup of the experiment. (B-D) 3 
Serological changes in Phl p 5-sensitized and rechallenged mice confirmed a TH2-polarized 4 
immune response. At the end of the experiment, sera were analyzed for (B) Phl p 5-specific 5 
IgG1and IgG2c, and (C) biologically functional IgE. (D) Serum levels of TH2 cytokines (IL-4, 6 
IL-5 and IL-13) and the TH2/Treg cytokine IL-10. (E) Serum levels of TH1/pro-inflammatory 7 
cytokines (IFNγ, TNFα, IL-1β, IL-2, IL-6) and the TH17 cytokine IL-17A. (F) Levels of the 8 
chemokines CCL2 and CCL11 and of (G) the growth factor VEGFα in the serum. Data are 9 
shown as means + S.D. (control: n = 9, allergy: n = 10). Statistical significance was 10 
determined using independent samples t-tests, multiplicity adjusted p values (Holm-Šídák 11 
correction for multiple t-tests) are reported in brackets (*p < 0.05, **p < 0.01, ***p < 0.001; 12 
n.s. – not significant). 13 
 14 
Figure 2 Cytokines and immune cells in bronchoalveolar lavage (BAL) fluid. Analysis of 15 
immune parameters in the BAL fluid confirmed a TH2-polarized immune reaction in the lungs 16 
of allergic mice. (A) BAL fluid levels of TH2 cytokines (IL-4, IL-5, and IL-13) and the 17 
TH2/Treg cytokine IL-10. (B) BAL fluid levels of the TH1 cytokine IFNγ, the TH17 cytokine 18 
IL-17A, and (C) the chemokine CCL11. (B) Immune cells which infiltrated into the lungs 19 
were analyzed in the BAL fluid using flow cytometry. Leukocytes, eosinophils, neutrophils, 20 
monocytes, T cells (CD4
+
 or CD8
+
) and CD19
+
 B cells were detected. Data are shown as 21 
means + S.D. (control: n = 9, allergy: n = 10). Statistical significance was determined using 22 
independent samples t-tests, multiplicity adjusted p values (Holm-Šídák correction for 23 
multiple t-tests) are reported in brackets (*p < 0.05, **p < 0.01, ***p < 0.001; n.s. – not 24 
significant). 25 
 26 
Figure 3 Reduced numbers of Iba1
+
 microglia and of microglia expressing MHCII in the 27 
hippocampal neurogenic niche of allergic mice. (A) Iba1
+
 microglia in the hippocampal 28 
dentate gyrus. (B) The number of Iba1
+
 cells in the GL and SGZ of the dentate gyrus is lower 29 
in allergic mice than in controls (C) Triple labelling of Iba1 (red), MHCII (green) and CD68 30 
(white). Cell nuclei are stained with DAPI (blue). Triple-positive cells are indicated by arrow 31 
heads. (D) The number of Iba1
+
MHCII
+
 cells was decreased in in the neurogenic niche of 32 
allergic mice, whereas (E) Iba1
+
CD68
+
 cells were not affected. Values are depicted as means 33 
+ S.D. (control: n = 9, allergy: n = 10). Statistical significance was evaluated using 34 
independent samples t-tests and is indicated in comparison to the control group (*p < 0.05, 35 
**p < 0.01, ***p < 0.001). Bars: (A) 100 µm, (C) 25 µm. 36 
 37 
Figure 4 Number of Iba1
+
MHCII
+
 and Iba1
+
CD68
+
 microglia is increased in the 38 
olfactory bulb (OB) of allergic mice. (A) Triple labelling of Iba1 (red), MHCII (green) and 39 
CD68 (white). Triple-positive cells are indicated by arrow heads. (B-C) Increased numbers of 40 
(B) Iba1
+
, (C) Iba1
+
MHCII
+
 and (D) Iba1
+
CD68
+
 cells in the granular cell layer of the OB. 41 
Values are depicted as means + S.D. (control: n = 9, allergy: n = 10). Statistical significance 42 
was evaluated using independent samples t-tests and is indicated in comparison to the control 43 
group (*p < 0.05, **p < 0.01, ***p < 0.001). Bars: 50 µm. 44 
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Figure 5 More DCX
+
 immature neurons, but unchanged cell proliferation, in the 1 
hippocampal dentate gyrus. (A) Proliferating cells stained with PCNA (arrowheads) in 2 
controls and the allergy group. (B) Allergic mice and controls had the same number of 3 
PCNA
+
 cells in GL and SGZ of the dentate gyrus. (C) DCX
+
 immature neurons in controls 4 
and allergy group. (D) Allergic mice had significantly more DCX
+
 cells in GL and SGZ. 5 
Values are depicted as means + S.D. (control: n = 9, allergy: n = 10). Statistical significance 6 
was evaluated using independent samples t-tests and is indicated in comparison to the control 7 
group (*p < 0.05, **p < 0.01, ***p < 0.001). Bars: 100 µm. 8 
 9 
Figure 6 More BrdU
+
 and BrdU
+
NeuN
+
 cells in the hippocampal dentate gyrus. (A) 10 
BrdU
+
 cells in the dentate gyrus. BrdU was injected once 4 weeks before the end of the 11 
experiment. (B) Increased number of BrdU
+
 cells in the hippocampal neurogenic niche in 12 
allergic mice. (C) Triple labelling of BrdU (green), NeuN
+
 mature neurons (red) and GFAP
+
 13 
astrocytes (white). BrdU
+
NeuN
+
 mature neurons are indicated by arrowheads. (D) In allergic 14 
mice not only the number of BrdU
+
 cells, but also of BrdU
+
NeuN
+
 mature neurons increased 15 
in comparison to controls. (E) The percentage of BrdU
+ 
cells which became mature NeuN
+
 16 
neurons or GFAP
+
 radial glia (or astrocytes) remained unchanged. Values are depicted as 17 
means + S.D. (control: n = 9, allergy: n = 10). Statistical significance was evaluated using 18 
independent samples t-tests and is indicated in comparison to the control group (*p < 0.05, 19 
**p < 0.01, ***p < 0.001). Bars: (A) 200 µm, (C) 25 µm. 20 
 21 
Figure 7 Unchanged number of BrdU
+
 cells in the SVZ and no changes in cell fate of 22 
BrdU
+
 cells in the OB. (A) BrdU-labelling in the SVZ in a control. Arrowheads indicate two 23 
BrdU
+
 cells. (B) There is no significant difference in the number of BrdU
+
 cells in the SVZ 24 
between controls and allergic mice. (C) BrdU-labelling in the OB. The rectangle in the first 25 
image on the left (taken of a control), indicates the region of the granular cell layer which was 26 
used for cell analyzes. The following confocal laser micrographs show a triple labelling of 27 
BrdU (green) NeuN (red) and GFAP (white). Arrowheads indicate three BrdU
+
NeuN
+
 cells. 28 
(B-C) Neither the percentage (B) nor the density (C) of BrdU
+
NeuN
+
 or BrdU
+
GFAP
+
 cells in 29 
the OB differs significantly between controls and allergic mice. Values are depicted as means 30 
+ S.D. (control: n = 9, allergy: n = 10). Statistical significance was evaluated using 31 
independent samples t-tests and is indicated in comparison to the control group (*p < 0.05, 32 
**p < 0.01, ***p < 0.001). Bars: (A) 200 µm, (C) 50 µm.  33 
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